FDA Inspection 1065396 — David R. Liljenquist, M.D.
The FDA completed an inspection of David R. Liljenquist, M.D. on Aug 3, 2018 in Idaho Falls, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 3, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Idaho Falls, ID (United States)
Additional Details
Clinical Investigator (CI)